Evidence Synthesis
NATHBIOGEN has accelerated its 53.76% over the previous period, up from 10.4%.
The company's also increased, while its and have seen improvements. However, the daily volume has been compared to 20,587 shares previously.
Evidence Synthesis
Last synthesized: 23 Aug 2026, 01:39
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
NATHBIOGEN has accelerated its 53.76% over the previous period, up from 10.4%.
The company's also increased, while its and have seen improvements. However, the daily volume has been compared to 20,587 shares previously.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.76 % | 10.4 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 10.4 % | 9.31 | ▲ |
| REVENUE_GROWTH_YOY | 15.8 % | -13.3 | ▲ |
| EPS_ACTUAL | 2.05 INR | 3.78 | ▼ |
| EPS_SURPRISE_PERCENT | -0.038 % | -0.135 | ▲ |
| PRICE_CHANGE_PERCENT | -0.546 % | — | - |
| DAILY_VOLUME | 5,335 shares | 20,587 | ▼ |
| CLOSE_PRICE | 153.09 INR | 153.93 | ▼ |